Human immune system layering and the neonatal response to vaccines
人体免疫系统分层和新生儿对疫苗的反应
基本信息
- 批准号:8091879
- 负责人:
- 金额:$ 23.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAntigensBirdsBirthBlood BanksBlood specimenBone MarrowCell LineageCell physiologyCellsChild health careChildhoodClinical SciencesCollaborationsCytotoxic T-LymphocytesDataDevelopmentDiseaseExhibitsExposure toFetal LiverFetusGeneral HospitalsGrowthHematopoieticHepatitis B VaccinationHumanImmune responseImmune systemImmunizationInfantInfectionInstitutesLymphocyteModalityMononuclearMusNeonatalNewborn InfantNormal RangePhysiologicalPopulationPredispositionProspective StudiesProtocols documentationPublic HealthResearchSamplingSan FranciscoStagingStem cellsSystemT-LymphocyteTimeTranslational ResearchUmbilical Cord BloodUniversity of Texas M D Anderson Cancer CenterVaccinationVaccinesVariantfetalin uteroneonateneutralizing antibodyresearch studyresponsestem
项目摘要
DESCRIPTION (provided by applicant): The development of the mammalian immune system is typically thought to occur in a linear fashion, from immaturity to maturity as a function of antigen exposure. Previous findings in birds and in mice, however, indicate that this view is oversimplified. Thus, in these species, the developing immune system appears to be "layered" in a manner that is independent of antigen exposure, beginning as a multilineage fetal system that is replaced by an anatomically and biologically distinct multilineage system after birth. If so, then developmentally ordered and unique hematopoietic stem/progenitor cells (HSPC) could give rise to distinct lymphocyte lineages at different stages of development. In ongoing experiments, we have found that such immune system "layering" occurs in humans. Our preliminary data show that a vigorous human fetal immune response to exogenous antigens can be actively suppressed by antigen-specific Tregs, that these fetal Tregs are derived from a fetal-specific lineage of T cells, and that this lineage is generated by an HSPC that is distinct from that found in adults. These data suggest that the human immune system is comprised of two distinct waves: one generated from a "fetal" HSPC that exists in utero in the fetal liver and bone marrow, and another generated from a superseding "adult" HSPC that resides in the bone marrow at later time points. The former gives rise to an immune system that is prone to deliver a tolerogenic response to foreign antigens. The latter gives rise to an immune system that is more likely to generate an immunoreactive response (e.g., one including cytotoxic T cells and neutralizing antibodies). Given these findings, we hypothesize that physiologic layering of immune system ontogeny leads to a normal range in the ratio of fetal- to adult-type T cells at birth, with some neonates exhibiting a higher fraction of fetal T cells than others; and that those with a high ratio of fetal/adult T cells will generate predominant Th2 responses to routine childhood immunizations. These hypotheses will be addressed in the experiments of the following Specific Aims: (1) to determine the normal range of fetal to adult T cells in the umbilical cord blood of the full term neonate; and (2) to determine whether those full term neonates with a high ratio of fetal/adult T cells are more likely to generate a Th2-polarized immune response to routine childhood vaccines. Should this exploratory study reveal normal variation in the ratio of fetal to adult T cells at birth and should such variation be directly related to a Th2 skew after childhood vaccination, modalities aimed at changing this ratio more towards the adult lineage at birth may provide benefit to a substantial number of newborns.
PUBLIC HEALTH RELEVANCE: These exploratory studies are relevant to public health for two reasons. First, they may provide proof-of- concept evidence for the existence of a range in the extent of immune system "layering" in human neonates. Secondly, they may demonstrate that this range is itself related to (and possibly causal of) differences in the ability of neonates to withstand infections and to respond to vaccines.
描述(由申请人提供):通常认为哺乳动物免疫系统的发展是以线性方式发生的,从不成熟到成熟作为抗原暴露的函数。然而,先前在鸟类和小鼠中的发现表明这种观点过于简单。因此,在这些物种中,发育中的免疫系统似乎以独立于抗原暴露的方式“分层”,从出生后被解剖和生物学上不同的多素养系统所取代的多节胎胎儿系统开始。如果是这样,那么发育有序的独特的造血干/祖细胞(HSPC)可能会在不同发育阶段引起独特的淋巴细胞谱系。在正在进行的实验中,我们发现这种免疫系统“分层”发生在人类中。我们的初步数据表明,可以通过抗原特异性Treg来积极抑制对外源抗原的剧烈胎儿免疫反应,这些胎儿Treg是从T细胞的胎儿特异性谱系中得出的,并且该谱系是由在成年人中发现的HSPC产生的。这些数据表明,人类免疫系统由两个不同的波动组成:一种由胎儿肝脏和骨髓中子宫中存在的“胎儿” HSPC产生,另一个是由后来时间点位于骨髓中的取代的“成人” HSPC产生的。前者产生的免疫系统很容易对外国抗原产生耐受性反应。后者产生一种免疫系统,该系统更可能产生免疫反应反应(例如,包括细胞毒性T细胞和中和抗体)。鉴于这些发现,我们假设免疫系统的生理分层导致出生时胎儿与成人型T细胞的比率正常,其中一些新生儿比其他新生儿表现出更高的胎儿T细胞分数。胎儿/成人T细胞比率高的人会产生对常规儿童免疫的主要反应。这些假设将在以下特定目的的实验中解决:(1)确定完整术语新生儿的脐带血液中胎儿对成年T细胞的正常范围; (2)确定那些胎儿/成人T细胞比率高的新术语是对常规儿童疫苗的Th2极化免疫反应的可能性。如果这项探索性研究揭示了出生时胎儿与成人T细胞比率正常的变化,并且如果这种变异与儿童疫苗接种后Th2偏斜直接相关,则旨在将这种比率更改为出生时成年谱系的方式可能会为大量新生儿提供益处。
公共卫生相关性:这些探索性研究与公共卫生有关,原因有两个。首先,他们可以为人类新生儿“分层”的范围存在范围的存在提供证明证据。其次,他们可以证明该范围本身与新生儿承受感染和对疫苗反应的能力的差异(可能以及可能因果关系)有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH M MCCUNE其他文献
JOSEPH M MCCUNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH M MCCUNE', 18)}}的其他基金
Timing of ART and homeostasis of the persistent HIV reservoir in the adult
ART 的时机和成人持续性 HIV 病毒库的稳态
- 批准号:
8921906 - 财政年份:2015
- 资助金额:
$ 23.18万 - 项目类别:
Novel flow cytometry-based assay for HIV-infected cells
基于流式细胞术的新型 HIV 感染细胞检测方法
- 批准号:
8774585 - 财政年份:2013
- 资助金额:
$ 23.18万 - 项目类别:
Novel flow cytometry-based assay for HIV-infected cells
基于流式细胞术的新型 HIV 感染细胞检测方法
- 批准号:
8656014 - 财政年份:2013
- 资助金额:
$ 23.18万 - 项目类别:
Layering of the human immune system, viral infections, and childhood asthma
人体免疫系统的分层、病毒感染和儿童哮喘
- 批准号:
8534024 - 财政年份:2012
- 资助金额:
$ 23.18万 - 项目类别:
Layering of the human immune system, viral infections, and childhood asthma
人体免疫系统的分层、病毒感染和儿童哮喘
- 批准号:
8298764 - 财政年份:2012
- 资助金额:
$ 23.18万 - 项目类别:
Mechanisms of effective adaptive immunity in HCV treatment
HCV 治疗中有效的适应性免疫机制
- 批准号:
8376379 - 财政年份:2012
- 资助金额:
$ 23.18万 - 项目类别:
Layering of the human immune system, viral infections, and childhood asthma
人体免疫系统的分层、病毒感染和儿童哮喘
- 批准号:
8689898 - 财政年份:2012
- 资助金额:
$ 23.18万 - 项目类别:
ROLE OF IMMUNE ACTIVATION IN SIV PATHOGENESIS
免疫激活在 SIV 发病机制中的作用
- 批准号:
8357276 - 财政年份:2011
- 资助金额:
$ 23.18万 - 项目类别:
INTERRUPTION OF MATERNAL-FETAL TRANSMISSION OF HIV
阻断 HIV 母婴传播
- 批准号:
8357331 - 财政年份:2011
- 资助金额:
$ 23.18万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 23.18万 - 项目类别:
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
- 批准号:
10641389 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
艰难梭菌疫苗的范德比尔特抗体和抗原发现
- 批准号:
10625686 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别: